期刊文献+

奥曲肽治疗肝硬化伴上消化道出血临床疗效观察 被引量:2

Clinical Study on Octreotide in the Treatment of Liver Cirrhosis With Upper Digestive Tract Bleeding
在线阅读 下载PDF
导出
摘要 目的 研究奥曲肽治疗肝硬化伴上消化道出血临床疗效。方法 此次研究纳入的对象来源于2014年6月-2016年4月我院收治肝硬化伴上消化道出血患者中随机抽取的48例。随机分为C组和A组,每组24例患者。C组采用垂体后叶素治疗,A组采用奥曲肽治疗。比较(1)肝硬化伴上消化道出血治疗效果;(2)止血时间、副作用发生率。结果(1)A组肝硬化伴上消化道出血治疗有效率高于C组,差异具有统计学意义(P〈0.05);(2)A组住院时间短于C组,副作用发生率低于C组,差异具有统计学意义(P〈0.05)。结论 奥曲肽治疗肝硬化伴上消化道出血治疗效果确切,可有效止血,减少副作用的发生,安全有效。 Objective To study the effect of octreotide in the treatment of liver cirrhosis with upper gastrointestinal bleeding.Methods 48 cases of patients with cirrhosis complicated with upper gastrointestinal bleeding in our hospital from June 2014 to April 2016. The above 48 cases of liver cirrhosis with upper gastrointestinal bleeding were randomly divided into C group of 24 cases and 24 cases of A group. Group C was treated with Pituitrin treatment, A group were treated with octreotide. To compare (1)the therapeutic effect of liver cirrhosis with upper gastrointestinal bleeding and (2)to stop the bleeding time and the incidence of side effects.Results (1) compared with the C group, the A group had more effect on the treatment of cirrhosis with upper gastrointestinal bleeding,P〈0.05; (2)compared with the A group,the hospitalization time was shorter,and the incidence of side effects was lower,P〈0.05.Conclusion Octreotide in the treatment of liver cirrhosis with upper digestive tract hemorrhage have exact curative effect, which can effectively stop bleeding, reduce the occurrence of side effects, safe and effective.
作者 龚珍民
出处 《中国继续医学教育》 2016年第28期161-162,共2页 China Continuing Medical Education
关键词 奥曲肽 肝硬化伴上消化道出血 治疗效果 Octreotide Liver cirrhosis with upper digestive tract hemorrhage Treatment effect
  • 相关文献

二级参考文献39

  • 1高保华.奥曲肽治疗非静脉曲张性上消化道出血102例疗效观察[J].陕西医学杂志,2006,35(5):624-624. 被引量:29
  • 2Nikoda V V, Bondarenko A V, Kiriushin D N, et al. Pre- vention of stress- induced damage of the upper gastrointesti- nal mucosa in patients during early postoperative period[J ]. Anesteziol Reanimatol, 2012(2) : 51.
  • 3Suk K T, Kim H S, Lee C S, et al. Clinical outcomes and risk factors of rebleeding following endoscopic therapy for nonvariceal upper gastrointestinal hemorrhage [ J , Clin En- dosc, 2011, 44(2): 93.
  • 4Rattanasupar A. Role of clinical parameters for predicting the cause of upper gastrointestinal bleeding [ J ]. J Med Assoc Thai, 2012, 95(1): 22.
  • 5Melinte- Popescu M, Blan G. The role of upper gastroin- testinal endoscopy in evaluation of portal hypertension [ J ]. Rev Med Chir Soc Med Nat Iasi, 2011, 115(4) : 1003.
  • 6Savi Z, Vracari V, Hadnadjev L, et al. Experience in the treatment of some complications of portal hypertension in al- coholic liver cirrhosis[J 1. Vojnosanit Pregl, 2011, 68 ( 11 ) : 917.
  • 7Gonzdlez E J, Rivera - Acosta J E, Sdnchez J M, et al. Management of upper gastrointestinal bleeding in cirrhotic pa- tients with documented esophageal varices evaluated at the Puerto Rico Medical Center[J]. Bol Asoc Med P R, 2011, 103(1): 5.
  • 8ANd S, Jafri W, Harnid S, et al. Terlipressin vs. octreotide in bleeding esophageal varices as an adjuvant therapy with en- doscopic band ligation: a randomized double- blind placebo- controlled trial J ]. Am J Gastroenterol, 2009, 104 ( 3 ) : 617.
  • 9Heidelbaugh J J, Sherbondy M. Cirrhosis and chronic liver failure: part II. Complications and treatment[J]. Am Faro Physician, 2006, 74(5): 767.
  • 10D'Amico G, De Franchis R, Cooperative Study Group. Up- per digestive bleeding in cirrhosis. Post - therapeutic outcome and prognostic indicators [ J ]. Hepatology, 2003, 38 ( 3 ) : 599.

同被引文献18

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部